Hollings Cancer Center Members
Mariam Alexander, M.D., Ph.D.
Assistant Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Thoracic Medical Oncology
Peggi Angel, Ph.D.
Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Molecular markers of cancer progression, outcome and therapies
Katherine Antel, M.D., Ph.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Lymphoma Biology
Evan Bagley, Ph.D.
Assistant Professor
Public Health Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Statistical design of early phase cancer trials and developing novel dose-finding methodology.
Lauren Ball, Ph.D.
Associate Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
To elucidate the mechanisms by which O-GlcNAc transferase modulates epigenetic regulators contributing to breast cancer stem cell initiation and metastasis
Praneeth Baratam, M.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Malignant hematology with a focus in leukemias, myelodysplastic syndromes and hematopoietic stem cell transplantation
Bhisham Chera, M.D.
Professor
Radiation Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Clinical translational trials for head and neck and skin cancers
Nathan Dolloff, Ph.D.
Associate Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Discovering small molecules and biologics (recombinant protein therapeutics, monoclonal and bispecific antibodies) that serve as tools to interrogate new mechanisms in cancer biology and as potential drug candidates for future development.
Richard Drake, Ph.D.
Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Discovery and validation of glycan and glycoprotein biomarkers in tissues, cells and biofluids for prostate, breast, pancreas, colon, kidney and liver cancers
Raymond DuBois, M.D., Ph.D.
Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Elucidating the role of inflammation and inflammatory mediators in the progression of colon cancer
Harriet Eldredge-Hindy, M.D.
Associate Professor
Radiation Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Clinical Oncology
Saverio Gentile, Ph.D.
Associate Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Effects and biochemical mechanism of pharmacological targeting ion channels in solid tumors.
Robert Grubb, M.D.
Professor
Urology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
My cancer research interest is in clinical trials for urologic cancers (including prostate, bladder, and kidney).
Dieter Haemmerich, Ph.D.
Professor
Pediatrics
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Loco-regional delivery of chemotherapy agents guided by imaging
Mark Hamann, Ph.D.
Professor
Drug Discovery & Biomedical Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
The discovery and development of new natural product inhibitors of cancer that provide new and unusual targets
Jennifer Harper, M.D.
Professor
Radiation Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Hypofractionated Radiotherapy
William Hawkins, M.D.
Professor
Surgery
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Novel Therapeutic Approaches to Pancreatic Cancer
Brian Hess, M.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Novel therapeutics in Hodgkin lymphoma (HL) and Diffuse Large B-cell Lymphoma (DLBCL)
Thai Ho, M.D., Ph.D.
Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Epigenetics of Kidney Cancer
Russell Jenkins, M.D., Ph.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
To develop novel therapeutic strategies to overcome immunotherapy resistance in melanoma and other cancers.
John Kaczmar, M.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Novel ways to evaluate response to immunotherapy and augment the response of patients to immune directed treatment approaches
Nancy Klauber-DeMore, M.D.
Professor
Surgery
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Mechanism of anti-SFRP2 therapy in cancer
Jacqueline Kraveka, M.D.
Professor
Pediatrics
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Neuroblastoma, pediatric sarcomas, pediatric precision medicine and clinical trial development
Brian Lally, M.D., F.A.C.R.O
Associate Professor
Radiation Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Clinical related research in Thoracic, GI, and GU malignancies
John Lemasters, M.D., Ph.D.
Professor
Drug Discovery & Biomedical Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Cellular and molecular mechanisms of apoptosis and necrosis
Scott Lindhorst, M.D.
Professor
Neurosurgery
Research Program
Developmental Cancer Therapeutics
Cancer Focus
My academic focus and clinical practice center around Neuro-Oncology, to include gliomas, CNS lymphoma, meningiomas, ependymomas, and neurofibromatosis.
A. Craig Lockhart, M.D., MHS
Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Clinical trials in gastric and esophageal cancers
David Marshall, M.D.
Professor
Radiation Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Clinical Trial Development
Shikhar Mehrotra, Ph.D.
Professor
Surgery
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Identification of signaling pathways and other chemo preventive agents as t-cell response modifiers
Anand Mehta, Ph.D.
Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Cancer Biomarkers
Jason Newman, M.D.
Professor
Otolaryngology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Head and Neck Cancer
Anna-Liisa Nieminen, Ph.D.
Professor
Drug Discovery & Biomedical Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Characterization of the pathophysiology of single living cells, including the assessment of ion homeostasis, and other biochemical parameters
John O'Bryan, Ph.D.
Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Developing novel approaches to inhibit oncogenic RAS
Besim Ogretmen, Ph.D.
Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Determining the mechanisms by which alterations in lipid metabolism and signaling regulate cancer growth, proliferation, metastasis, and response to chemotherapy or immunotherapy modalities
Brian Orr, M.D.
Associate Professor
Obstetrics & Gynecology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
I am broadly active in translational science, clinical trials, prevention, novel surgical approaches, and survivorship to improving gynecologic cancers.
Yuri Peterson, Ph.D.
Professor
Drug Discovery & Biomedical Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Hormone driven and refractory cancers, cell signaling, bioenergetics, general drug discovery, biomarkers
Don Rockey, M.D.
Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
New pathways important in patients with liver disease and the molecular basis of portal hypertension
Abirami Sivapiragasam, M.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Breast Cancer Research
Russell Spencer-Smith, Ph.D.
Assistant Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
To uncover new functional regions and novel drug targets in the RAS-MAPK pathway through the study of rare disease-associated mutations
Daniel Sprague, M.D., Ph.D.
Assistant Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Drug discovery, medicinal chemistry, and the elucidation of underlying receptor pharmacology to develop new anticancer therapeutics
Kenneth Tew, Ph.D.
Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Redox in drug development and mechanism
Christina Voelkel-Johnson, Ph.D.
Associate Professor
Biochemistry & Molecular Biology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Identification of novel signaling pathways/interaction within cancer cells or cancer-immune cell interactions that can be targeted therapeutically to improve therapy efficacy and/or prevent cancer relapse/recurrence
Eric Wallen, M.D.
Professor
Urology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Prostate, kidney, bladder, testis cancer community-based, translational, survivorship, and outcomes.
Haizhen Wang, Ph.D.
Associate Professor
Pharmacology & Immunology
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Exploring the mechanisms of leukemia infiltration and immune evasion
John Wrangle, M.D.
Associate Professor
Medicine
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Novel therapeutic strategies and biomarkers for the treatment of non-small cell lung cancer
Zhi Zhong, M.D., Ph.D.
Professor
Drug Discovery & Biomedical Sciences
Research Program
Developmental Cancer Therapeutics
Cancer Focus
Hepatology and toxicology, especially on the roles of free radicals and mitochondrial dysfunction in liver injury, inflammation and fibrosis